Meanwhile, the downregulation of IFN-β was observed in mild COVID-19 patients (31.6 ± 3.7 in mild COVID-19 patients vs 47.3 ± 6.9 in healthy controls; Fig. 3b; P < 0.01). This evidence concerns the gene IFNB1 and COVID-19.